nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—CYP2C18—Ifosfamide—germ cell cancer	0.143	0.203	CbGbCtD
Lidocaine—SLC22A5—Dactinomycin—germ cell cancer	0.0777	0.11	CbGbCtD
Lidocaine—CYP2A6—Ifosfamide—germ cell cancer	0.0697	0.0986	CbGbCtD
Lidocaine—CYP3A7—Ifosfamide—germ cell cancer	0.0477	0.0674	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0477	0.0674	CbGbCtD
Lidocaine—CYP2B6—Ifosfamide—germ cell cancer	0.0454	0.0642	CbGbCtD
Lidocaine—CYP3A5—Ifosfamide—germ cell cancer	0.0358	0.0506	CbGbCtD
Lidocaine—CYP2C8—Ifosfamide—germ cell cancer	0.0344	0.0486	CbGbCtD
Lidocaine—CYP2C9—Ifosfamide—germ cell cancer	0.024	0.0339	CbGbCtD
Lidocaine—CYP2B6—Cisplatin—germ cell cancer	0.0221	0.0312	CbGbCtD
Lidocaine—ABCB1—Dactinomycin—germ cell cancer	0.0197	0.0279	CbGbCtD
Lidocaine—CYP3A5—Etoposide—germ cell cancer	0.0171	0.0242	CbGbCtD
Lidocaine—CYP2C8—Etoposide—germ cell cancer	0.0164	0.0232	CbGbCtD
Lidocaine—CYP3A4—Ifosfamide—germ cell cancer	0.0139	0.0197	CbGbCtD
Lidocaine—CYP1A2—Etoposide—germ cell cancer	0.0127	0.018	CbGbCtD
Lidocaine—ABCB1—Vinblastine—germ cell cancer	0.0123	0.0175	CbGbCtD
Lidocaine—CYP2C9—Cisplatin—germ cell cancer	0.0117	0.0165	CbGbCtD
Lidocaine—CYP2D6—Vinblastine—germ cell cancer	0.0116	0.0164	CbGbCtD
Lidocaine—ABCB1—Cisplatin—germ cell cancer	0.0113	0.016	CbGbCtD
Lidocaine—ABCB1—Etoposide—germ cell cancer	0.0111	0.0157	CbGbCtD
Lidocaine—SCN3A—spinal nerve—germ cell cancer	0.00908	0.137	CbGeAlD
Lidocaine—CYP3A4—Vinblastine—germ cell cancer	0.0074	0.0105	CbGbCtD
Lidocaine—ABCB1—Methotrexate—germ cell cancer	0.00735	0.0104	CbGbCtD
Lidocaine—CYP3A4—Etoposide—germ cell cancer	0.00666	0.00942	CbGbCtD
Lidocaine—CYP2C9—cardial valve—germ cell cancer	0.00586	0.0883	CbGeAlD
Lidocaine—SCN10A—ganglion—germ cell cancer	0.0019	0.0286	CbGeAlD
Lidocaine—Slurred speech—Cisplatin—germ cell cancer	0.0016	0.00966	CcSEcCtD
Lidocaine—Acidosis—Ifosfamide—germ cell cancer	0.0015	0.00905	CcSEcCtD
Lidocaine—Numbness—Vinblastine—germ cell cancer	0.00138	0.00837	CcSEcCtD
Lidocaine—CYP1A2—urine—germ cell cancer	0.00133	0.0201	CbGeAlD
Lidocaine—Sensory loss—Vinblastine—germ cell cancer	0.00132	0.00801	CcSEcCtD
Lidocaine—Procainamide—SLC22A3—germ cell cancer	0.0013	1	CrCbGaD
Lidocaine—CYP2C9—urine—germ cell cancer	0.00126	0.019	CbGeAlD
Lidocaine—Hyperaesthesia—Bleomycin—germ cell cancer	0.00123	0.00747	CcSEcCtD
Lidocaine—Taste metallic—Methotrexate—germ cell cancer	0.00123	0.00745	CcSEcCtD
Lidocaine—SCN9A—trigeminal ganglion—germ cell cancer	0.00122	0.0184	CbGeAlD
Lidocaine—EGFR—telencephalon—germ cell cancer	0.00117	0.0176	CbGeAlD
Lidocaine—Tenderness—Bleomycin—germ cell cancer	0.00111	0.00672	CcSEcCtD
Lidocaine—Ventricular fibrillation—Ifosfamide—germ cell cancer	0.00108	0.00654	CcSEcCtD
Lidocaine—Neurotoxicity—Methotrexate—germ cell cancer	0.00101	0.00611	CcSEcCtD
Lidocaine—Petechiae—Ifosfamide—germ cell cancer	0.00101	0.00609	CcSEcCtD
Lidocaine—EGFR—uterus—germ cell cancer	0.000967	0.0146	CbGeAlD
Lidocaine—CYP3A4—urine—germ cell cancer	0.000963	0.0145	CbGeAlD
Lidocaine—Tenderness—Ifosfamide—germ cell cancer	0.000949	0.00574	CcSEcCtD
Lidocaine—CYP2D6—urine—germ cell cancer	0.000948	0.0143	CbGeAlD
Lidocaine—SCN10A—trigeminal ganglion—germ cell cancer	0.000931	0.014	CbGeAlD
Lidocaine—Skin exfoliation—Bleomycin—germ cell cancer	0.000925	0.0056	CcSEcCtD
Lidocaine—Leukoderma—Methotrexate—germ cell cancer	0.000922	0.00558	CcSEcCtD
Lidocaine—Laryngospasm—Etoposide—germ cell cancer	0.000876	0.0053	CcSEcCtD
Lidocaine—Dysarthria—Ifosfamide—germ cell cancer	0.000876	0.0053	CcSEcCtD
Lidocaine—SCN2A—brainstem—germ cell cancer	0.000855	0.0129	CbGeAlD
Lidocaine—EGFR—adrenal gland—germ cell cancer	0.000849	0.0128	CbGeAlD
Lidocaine—Muscle twitching—Ifosfamide—germ cell cancer	0.000843	0.0051	CcSEcCtD
Lidocaine—Ventricular tachycardia—Ifosfamide—germ cell cancer	0.000828	0.00501	CcSEcCtD
Lidocaine—Tenderness—Cisplatin—germ cell cancer	0.000818	0.00495	CcSEcCtD
Lidocaine—Depressed level of consciousness—Ifosfamide—germ cell cancer	0.0008	0.00484	CcSEcCtD
Lidocaine—Urinary incontinence—Ifosfamide—germ cell cancer	0.0008	0.00484	CcSEcCtD
Lidocaine—EGFR—female gonad—germ cell cancer	0.000791	0.0119	CbGeAlD
Lidocaine—Skin exfoliation—Ifosfamide—germ cell cancer	0.000791	0.00478	CcSEcCtD
Lidocaine—Numbness—Etoposide—germ cell cancer	0.000789	0.00477	CcSEcCtD
Lidocaine—Disorientation—Bleomycin—germ cell cancer	0.000786	0.00476	CcSEcCtD
Lidocaine—SCN9A—pituitary gland—germ cell cancer	0.000782	0.0118	CbGeAlD
Lidocaine—Apnoea—Etoposide—germ cell cancer	0.000772	0.00467	CcSEcCtD
Lidocaine—SCN2A—telencephalon—germ cell cancer	0.000758	0.0114	CbGeAlD
Lidocaine—Coma—Ifosfamide—germ cell cancer	0.000757	0.00458	CcSEcCtD
Lidocaine—Sensory loss—Etoposide—germ cell cancer	0.000755	0.00457	CcSEcCtD
Lidocaine—Dysarthria—Cisplatin—germ cell cancer	0.000755	0.00457	CcSEcCtD
Lidocaine—SCN10A—telencephalon—germ cell cancer	0.000731	0.011	CbGeAlD
Lidocaine—EGFR—testis—germ cell cancer	0.000702	0.0106	CbGeAlD
Lidocaine—SCN9A—adrenal gland—germ cell cancer	0.000699	0.0105	CbGeAlD
Lidocaine—SCN4A—pituitary gland—germ cell cancer	0.000698	0.0105	CbGeAlD
Lidocaine—SCN9A—midbrain—germ cell cancer	0.00069	0.0104	CbGeAlD
Lidocaine—Skin exfoliation—Cisplatin—germ cell cancer	0.000682	0.00412	CcSEcCtD
Lidocaine—SCN9A—spinal cord—germ cell cancer	0.000673	0.0101	CbGeAlD
Lidocaine—Disorientation—Ifosfamide—germ cell cancer	0.000672	0.00407	CcSEcCtD
Lidocaine—Neuropathy—Cisplatin—germ cell cancer	0.00067	0.00406	CcSEcCtD
Lidocaine—SCN3A—telencephalon—germ cell cancer	0.000667	0.0101	CbGeAlD
Lidocaine—EGFR—cerebellum—germ cell cancer	0.000648	0.00977	CbGeAlD
Lidocaine—CYP2C18—endocrine gland—germ cell cancer	0.000636	0.00959	CbGeAlD
Lidocaine—SCN3A—decidua—germ cell cancer	0.000632	0.00953	CbGeAlD
Lidocaine—Neuropathy peripheral—Vinblastine—germ cell cancer	0.000629	0.00381	CcSEcCtD
Lidocaine—Skin exfoliation—Etoposide—germ cell cancer	0.000624	0.00378	CcSEcCtD
Lidocaine—SCN4A—adrenal gland—germ cell cancer	0.000623	0.0094	CbGeAlD
Lidocaine—SCN2A—pituitary gland—germ cell cancer	0.000618	0.00931	CbGeAlD
Lidocaine—Neuropathy—Etoposide—germ cell cancer	0.000614	0.00372	CcSEcCtD
Lidocaine—CYP3A7—endocrine gland—germ cell cancer	0.000605	0.00912	CbGeAlD
Lidocaine—Osteoarthritis—Ifosfamide—germ cell cancer	0.000601	0.00364	CcSEcCtD
Lidocaine—Bronchospasm—Bleomycin—germ cell cancer	0.000598	0.00362	CcSEcCtD
Lidocaine—SCN2A—medulla oblongata—germ cell cancer	0.000596	0.00899	CbGeAlD
Lidocaine—SCN10A—pituitary gland—germ cell cancer	0.000595	0.00898	CbGeAlD
Lidocaine—Psychotic disorder—Ifosfamide—germ cell cancer	0.000587	0.00355	CcSEcCtD
Lidocaine—Haemoglobin—Vinblastine—germ cell cancer	0.000579	0.0035	CcSEcCtD
Lidocaine—SCN9A—testis—germ cell cancer	0.000578	0.00871	CbGeAlD
Lidocaine—Haemorrhage—Vinblastine—germ cell cancer	0.000576	0.00349	CcSEcCtD
Lidocaine—Hypoaesthesia—Vinblastine—germ cell cancer	0.000573	0.00347	CcSEcCtD
Lidocaine—Cardiac arrest—Ifosfamide—germ cell cancer	0.000572	0.00346	CcSEcCtD
Lidocaine—Urinary retention—Ifosfamide—germ cell cancer	0.000572	0.00346	CcSEcCtD
Lidocaine—Dysphagia—Dactinomycin—germ cell cancer	0.000567	0.00343	CcSEcCtD
Lidocaine—Paralysis—Methotrexate—germ cell cancer	0.000564	0.00341	CcSEcCtD
Lidocaine—Burning sensation—Methotrexate—germ cell cancer	0.000564	0.00341	CcSEcCtD
Lidocaine—SCN2A—midbrain—germ cell cancer	0.000545	0.00821	CbGeAlD
Lidocaine—SCN3A—pituitary gland—germ cell cancer	0.000543	0.00818	CbGeAlD
Lidocaine—Anaphylactoid reaction—Cisplatin—germ cell cancer	0.000535	0.00324	CcSEcCtD
Lidocaine—SCN4A—head—germ cell cancer	0.000534	0.00805	CbGeAlD
Lidocaine—SCN2A—spinal cord—germ cell cancer	0.000531	0.00801	CbGeAlD
Lidocaine—Stomatitis—Bleomycin—germ cell cancer	0.000528	0.0032	CcSEcCtD
Lidocaine—EGFR—brain—germ cell cancer	0.000526	0.00794	CbGeAlD
Lidocaine—SCN3A—medulla oblongata—germ cell cancer	0.000524	0.0079	CbGeAlD
Lidocaine—SCN4A—testis—germ cell cancer	0.000516	0.00777	CbGeAlD
Lidocaine—SCN10A—spinal cord—germ cell cancer	0.000512	0.00773	CbGeAlD
Lidocaine—Bronchospasm—Ifosfamide—germ cell cancer	0.000511	0.00309	CcSEcCtD
Lidocaine—EGFR—lymph node—germ cell cancer	0.000509	0.00767	CbGeAlD
Lidocaine—Gingivitis—Methotrexate—germ cell cancer	0.000499	0.00302	CcSEcCtD
Lidocaine—Stomatitis—Dactinomycin—germ cell cancer	0.000493	0.00298	CcSEcCtD
Lidocaine—SLC22A5—trigeminal ganglion—germ cell cancer	0.000492	0.00742	CbGeAlD
Lidocaine—Anaphylactoid reaction—Etoposide—germ cell cancer	0.000491	0.00297	CcSEcCtD
Lidocaine—Haemoglobin—Bleomycin—germ cell cancer	0.000489	0.00296	CcSEcCtD
Lidocaine—Haemorrhage—Bleomycin—germ cell cancer	0.000487	0.00294	CcSEcCtD
Lidocaine—SCN3A—adrenal gland—germ cell cancer	0.000485	0.00731	CbGeAlD
Lidocaine—Hypoaesthesia—Bleomycin—germ cell cancer	0.000484	0.00293	CcSEcCtD
Lidocaine—SCN3A—midbrain—germ cell cancer	0.000479	0.00722	CbGeAlD
Lidocaine—SCN2A—endocrine gland—germ cell cancer	0.000478	0.00721	CbGeAlD
Lidocaine—Petechiae—Methotrexate—germ cell cancer	0.000476	0.00288	CcSEcCtD
Lidocaine—SCN2A—head—germ cell cancer	0.000472	0.00712	CbGeAlD
Lidocaine—SCN3A—bone marrow—germ cell cancer	0.000469	0.00707	CbGeAlD
Lidocaine—SCN3A—spinal cord—germ cell cancer	0.000467	0.00704	CbGeAlD
Lidocaine—Apnoea—Methotrexate—germ cell cancer	0.000462	0.0028	CcSEcCtD
Lidocaine—SCN10A—endocrine gland—germ cell cancer	0.000461	0.00696	CbGeAlD
Lidocaine—SCN10A—head—germ cell cancer	0.000455	0.00687	CbGeAlD
Lidocaine—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.000454	0.00275	CcSEcCtD
Lidocaine—Flushing—Bleomycin—germ cell cancer	0.000452	0.00273	CcSEcCtD
Lidocaine—Stomatitis—Ifosfamide—germ cell cancer	0.000452	0.00273	CcSEcCtD
Lidocaine—Cardiac arrest—Etoposide—germ cell cancer	0.000451	0.00273	CcSEcCtD
Lidocaine—Chills—Bleomycin—germ cell cancer	0.000437	0.00264	CcSEcCtD
Lidocaine—Sweating increased—Cisplatin—germ cell cancer	0.000436	0.00264	CcSEcCtD
Lidocaine—Convulsion—Vinblastine—germ cell cancer	0.000435	0.00263	CcSEcCtD
Lidocaine—SCN9A—brain—germ cell cancer	0.000433	0.00654	CbGeAlD
Lidocaine—Hypertension—Vinblastine—germ cell cancer	0.000433	0.00262	CcSEcCtD
Lidocaine—Erythema—Bleomycin—germ cell cancer	0.000424	0.00256	CcSEcCtD
Lidocaine—Bradycardia—Ifosfamide—germ cell cancer	0.000423	0.00256	CcSEcCtD
Lidocaine—SCN2A—cerebellum—germ cell cancer	0.000421	0.00635	CbGeAlD
Lidocaine—Flushing—Dactinomycin—germ cell cancer	0.000421	0.00255	CcSEcCtD
Lidocaine—SLC22A5—retina—germ cell cancer	0.00042	0.00633	CbGeAlD
Lidocaine—SCN9A—lymph node—germ cell cancer	0.000419	0.00632	CbGeAlD
Lidocaine—Haemoglobin—Ifosfamide—germ cell cancer	0.000418	0.00253	CcSEcCtD
Lidocaine—Haemorrhage—Ifosfamide—germ cell cancer	0.000416	0.00252	CcSEcCtD
Lidocaine—SCN3A—head—germ cell cancer	0.000415	0.00626	CbGeAlD
Lidocaine—Dysarthria—Methotrexate—germ cell cancer	0.000414	0.00251	CcSEcCtD
Lidocaine—SCN5A—head—germ cell cancer	0.000414	0.00624	CbGeAlD
Lidocaine—Dysphagia—Etoposide—germ cell cancer	0.00041	0.00248	CcSEcCtD
Lidocaine—Chills—Dactinomycin—germ cell cancer	0.000407	0.00246	CcSEcCtD
Lidocaine—Bronchospasm—Etoposide—germ cell cancer	0.000404	0.00244	CcSEcCtD
Lidocaine—SCN3A—testis—germ cell cancer	0.000401	0.00605	CbGeAlD
Lidocaine—Visual impairment—Ifosfamide—germ cell cancer	0.000401	0.00243	CcSEcCtD
Lidocaine—Sweating increased—Etoposide—germ cell cancer	0.0004	0.00242	CcSEcCtD
Lidocaine—Erythema—Dactinomycin—germ cell cancer	0.000395	0.00239	CcSEcCtD
Lidocaine—Neuropathy peripheral—Cisplatin—germ cell cancer	0.000391	0.00237	CcSEcCtD
Lidocaine—Stomatitis—Cisplatin—germ cell cancer	0.000389	0.00236	CcSEcCtD
Lidocaine—Eye disorder—Ifosfamide—germ cell cancer	0.000389	0.00235	CcSEcCtD
Lidocaine—Tinnitus—Ifosfamide—germ cell cancer	0.000388	0.00235	CcSEcCtD
Lidocaine—SCN4A—brain—germ cell cancer	0.000387	0.00583	CbGeAlD
Lidocaine—Flushing—Ifosfamide—germ cell cancer	0.000386	0.00234	CcSEcCtD
Lidocaine—Cardiac disorder—Ifosfamide—germ cell cancer	0.000386	0.00234	CcSEcCtD
Lidocaine—Depressed level of consciousness—Methotrexate—germ cell cancer	0.000378	0.00229	CcSEcCtD
Lidocaine—Angiopathy—Ifosfamide—germ cell cancer	0.000377	0.00228	CcSEcCtD
Lidocaine—Immune system disorder—Ifosfamide—germ cell cancer	0.000376	0.00227	CcSEcCtD
Lidocaine—Skin exfoliation—Methotrexate—germ cell cancer	0.000374	0.00226	CcSEcCtD
Lidocaine—Chills—Ifosfamide—germ cell cancer	0.000373	0.00226	CcSEcCtD
Lidocaine—SCN3A—cerebellum—germ cell cancer	0.00037	0.00558	CbGeAlD
Lidocaine—CYP2A6—cerebellum—germ cell cancer	0.00037	0.00558	CbGeAlD
Lidocaine—ABCB1—blood vessel—germ cell cancer	0.00037	0.00557	CbGeAlD
Lidocaine—SLC22A5—skin of body—germ cell cancer	0.000369	0.00556	CbGeAlD
Lidocaine—Paraesthesia—Vinblastine—germ cell cancer	0.000368	0.00222	CcSEcCtD
Lidocaine—Bradycardia—Cisplatin—germ cell cancer	0.000365	0.00221	CcSEcCtD
Lidocaine—Erythema—Ifosfamide—germ cell cancer	0.000362	0.00219	CcSEcCtD
Lidocaine—Chest pain—Bleomycin—germ cell cancer	0.000361	0.00218	CcSEcCtD
Lidocaine—Neuropathy peripheral—Etoposide—germ cell cancer	0.000359	0.00217	CcSEcCtD
Lidocaine—Coma—Methotrexate—germ cell cancer	0.000358	0.00217	CcSEcCtD
Lidocaine—Stomatitis—Etoposide—germ cell cancer	0.000357	0.00216	CcSEcCtD
Lidocaine—Pain—Vinblastine—germ cell cancer	0.00035	0.00212	CcSEcCtD
Lidocaine—Confusional state—Bleomycin—germ cell cancer	0.000349	0.00211	CcSEcCtD
Lidocaine—Oedema—Bleomycin—germ cell cancer	0.000346	0.00209	CcSEcCtD
Lidocaine—Anaphylactic shock—Bleomycin—germ cell cancer	0.000346	0.00209	CcSEcCtD
Lidocaine—Visual impairment—Cisplatin—germ cell cancer	0.000345	0.00209	CcSEcCtD
Lidocaine—SCN2A—brain—germ cell cancer	0.000342	0.00516	CbGeAlD
Lidocaine—Vision blurred—Ifosfamide—germ cell cancer	0.000341	0.00206	CcSEcCtD
Lidocaine—Feeling abnormal—Vinblastine—germ cell cancer	0.000337	0.00204	CcSEcCtD
Lidocaine—Eye disorder—Cisplatin—germ cell cancer	0.000335	0.00203	CcSEcCtD
Lidocaine—Tinnitus—Cisplatin—germ cell cancer	0.000334	0.00202	CcSEcCtD
Lidocaine—Flushing—Cisplatin—germ cell cancer	0.000333	0.00201	CcSEcCtD
Lidocaine—Cardiac disorder—Cisplatin—germ cell cancer	0.000333	0.00201	CcSEcCtD
Lidocaine—Agitation—Ifosfamide—germ cell cancer	0.000333	0.00201	CcSEcCtD
Lidocaine—Angioedema—Ifosfamide—germ cell cancer	0.000331	0.002	CcSEcCtD
Lidocaine—SCN10A—brain—germ cell cancer	0.00033	0.00498	CbGeAlD
Lidocaine—Hypoaesthesia—Etoposide—germ cell cancer	0.000327	0.00198	CcSEcCtD
Lidocaine—Immune system disorder—Cisplatin—germ cell cancer	0.000324	0.00196	CcSEcCtD
Lidocaine—Hypotension—Bleomycin—germ cell cancer	0.000323	0.00195	CcSEcCtD
Lidocaine—Oedema—Dactinomycin—germ cell cancer	0.000322	0.00195	CcSEcCtD
Lidocaine—CYP2B6—skin of body—germ cell cancer	0.00032	0.00483	CbGeAlD
Lidocaine—SCN10A—lymph node—germ cell cancer	0.000319	0.00481	CbGeAlD
Lidocaine—SLC22A5—pituitary gland—germ cell cancer	0.000314	0.00474	CbGeAlD
Lidocaine—Convulsion—Ifosfamide—germ cell cancer	0.000314	0.0019	CcSEcCtD
Lidocaine—Hypertension—Ifosfamide—germ cell cancer	0.000313	0.00189	CcSEcCtD
Lidocaine—Erythema—Cisplatin—germ cell cancer	0.000312	0.00189	CcSEcCtD
Lidocaine—Paraesthesia—Bleomycin—germ cell cancer	0.00031	0.00188	CcSEcCtD
Lidocaine—Dyspnoea—Bleomycin—germ cell cancer	0.000308	0.00186	CcSEcCtD
Lidocaine—Chest pain—Ifosfamide—germ cell cancer	0.000308	0.00186	CcSEcCtD
Lidocaine—Eye disorder—Etoposide—germ cell cancer	0.000307	0.00186	CcSEcCtD
Lidocaine—Cardiac disorder—Etoposide—germ cell cancer	0.000305	0.00184	CcSEcCtD
Lidocaine—Flushing—Etoposide—germ cell cancer	0.000305	0.00184	CcSEcCtD
Lidocaine—CYP2C8—pituitary gland—germ cell cancer	0.000304	0.00459	CbGeAlD
Lidocaine—SLC22A5—medulla oblongata—germ cell cancer	0.000303	0.00458	CbGeAlD
Lidocaine—Hypersensitivity—Vinblastine—germ cell cancer	0.000302	0.00182	CcSEcCtD
Lidocaine—SCN3A—brain—germ cell cancer	0.000301	0.00454	CbGeAlD
Lidocaine—CYP2A6—brain—germ cell cancer	0.000301	0.00453	CbGeAlD
Lidocaine—Visual disturbance—Methotrexate—germ cell cancer	0.0003	0.00182	CcSEcCtD
Lidocaine—SCN5A—brain—germ cell cancer	0.0003	0.00452	CbGeAlD
Lidocaine—Angiopathy—Etoposide—germ cell cancer	0.000298	0.0018	CcSEcCtD
Lidocaine—Confusional state—Ifosfamide—germ cell cancer	0.000298	0.0018	CcSEcCtD
Lidocaine—Immune system disorder—Etoposide—germ cell cancer	0.000297	0.0018	CcSEcCtD
Lidocaine—Pain—Bleomycin—germ cell cancer	0.000296	0.00179	CcSEcCtD
Lidocaine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000295	0.00179	CcSEcCtD
Lidocaine—Oedema—Ifosfamide—germ cell cancer	0.000295	0.00179	CcSEcCtD
Lidocaine—Chills—Etoposide—germ cell cancer	0.000295	0.00178	CcSEcCtD
Lidocaine—Vision blurred—Cisplatin—germ cell cancer	0.000294	0.00178	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000294	0.00178	CcSEcCtD
Lidocaine—Asthenia—Vinblastine—germ cell cancer	0.000294	0.00178	CcSEcCtD
Lidocaine—Tremor—Cisplatin—germ cell cancer	0.000292	0.00177	CcSEcCtD
Lidocaine—SCN3A—lymph node—germ cell cancer	0.000291	0.00438	CbGeAlD
Lidocaine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00029	0.00175	CcSEcCtD
Lidocaine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000286	0.00173	CcSEcCtD
Lidocaine—Feeling abnormal—Bleomycin—germ cell cancer	0.000285	0.00172	CcSEcCtD
Lidocaine—Osteoarthritis—Methotrexate—germ cell cancer	0.000284	0.00172	CcSEcCtD
Lidocaine—SLC22A5—adrenal gland—germ cell cancer	0.000281	0.00424	CbGeAlD
Lidocaine—CYP2D6—brainstem—germ cell cancer	0.000281	0.00423	CbGeAlD
Lidocaine—Dysgeusia—Etoposide—germ cell cancer	0.00028	0.00169	CcSEcCtD
Lidocaine—CYP2B6—gonad—germ cell cancer	0.00028	0.00422	CbGeAlD
Lidocaine—SLC22A5—midbrain—germ cell cancer	0.000277	0.00418	CbGeAlD
Lidocaine—Back pain—Etoposide—germ cell cancer	0.000277	0.00167	CcSEcCtD
Lidocaine—Hypotension—Ifosfamide—germ cell cancer	0.000276	0.00167	CcSEcCtD
Lidocaine—Pain—Dactinomycin—germ cell cancer	0.000276	0.00167	CcSEcCtD
Lidocaine—Urticaria—Bleomycin—germ cell cancer	0.000275	0.00166	CcSEcCtD
Lidocaine—Dizziness—Vinblastine—germ cell cancer	0.000271	0.00164	CcSEcCtD
Lidocaine—SLC22A5—spinal cord—germ cell cancer	0.000271	0.00408	CbGeAlD
Lidocaine—Convulsion—Cisplatin—germ cell cancer	0.00027	0.00164	CcSEcCtD
Lidocaine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000266	0.00161	CcSEcCtD
Lidocaine—Paraesthesia—Ifosfamide—germ cell cancer	0.000265	0.00161	CcSEcCtD
Lidocaine—Anxiety—Cisplatin—germ cell cancer	0.000265	0.0016	CcSEcCtD
Lidocaine—Dyspnoea—Ifosfamide—germ cell cancer	0.000263	0.00159	CcSEcCtD
Lidocaine—Somnolence—Ifosfamide—germ cell cancer	0.000263	0.00159	CcSEcCtD
Lidocaine—SLC22A5—female gonad—germ cell cancer	0.000262	0.00395	CbGeAlD
Lidocaine—Vomiting—Vinblastine—germ cell cancer	0.00026	0.00157	CcSEcCtD
Lidocaine—Headache—Vinblastine—germ cell cancer	0.000256	0.00155	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000255	0.00154	CcSEcCtD
Lidocaine—Oedema—Cisplatin—germ cell cancer	0.000255	0.00154	CcSEcCtD
Lidocaine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000255	0.00154	CcSEcCtD
Lidocaine—Hypersensitivity—Bleomycin—germ cell cancer	0.000255	0.00154	CcSEcCtD
Lidocaine—Pain—Ifosfamide—germ cell cancer	0.000253	0.00153	CcSEcCtD
Lidocaine—Loss of consciousness—Etoposide—germ cell cancer	0.000251	0.00152	CcSEcCtD
Lidocaine—Nervous system disorder—Cisplatin—germ cell cancer	0.00025	0.00151	CcSEcCtD
Lidocaine—CYP2D6—telencephalon—germ cell cancer	0.000249	0.00376	CbGeAlD
Lidocaine—Asthenia—Bleomycin—germ cell cancer	0.000248	0.0015	CcSEcCtD
Lidocaine—Convulsion—Etoposide—germ cell cancer	0.000248	0.0015	CcSEcCtD
Lidocaine—Hypertension—Etoposide—germ cell cancer	0.000247	0.00149	CcSEcCtD
Lidocaine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000246	0.00149	CcSEcCtD
Lidocaine—Asthma—Methotrexate—germ cell cancer	0.000246	0.00149	CcSEcCtD
Lidocaine—CYP2B6—adrenal gland—germ cell cancer	0.000244	0.00368	CbGeAlD
Lidocaine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000243	0.00147	CcSEcCtD
Lidocaine—Chest pain—Etoposide—germ cell cancer	0.000243	0.00147	CcSEcCtD
Lidocaine—Nausea—Vinblastine—germ cell cancer	0.000243	0.00147	CcSEcCtD
Lidocaine—Hypotension—Cisplatin—germ cell cancer	0.000238	0.00144	CcSEcCtD
Lidocaine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000238	0.00144	CcSEcCtD
Lidocaine—CYP2C8—endocrine gland—germ cell cancer	0.000236	0.00356	CbGeAlD
Lidocaine—Confusional state—Etoposide—germ cell cancer	0.000235	0.00142	CcSEcCtD
Lidocaine—Urticaria—Ifosfamide—germ cell cancer	0.000235	0.00142	CcSEcCtD
Lidocaine—Anaphylactic shock—Etoposide—germ cell cancer	0.000233	0.00141	CcSEcCtD
Lidocaine—SLC22A5—testis—germ cell cancer	0.000232	0.0035	CbGeAlD
Lidocaine—Asthenia—Dactinomycin—germ cell cancer	0.000231	0.0014	CcSEcCtD
Lidocaine—CYP3A5—female gonad—germ cell cancer	0.000229	0.00345	CbGeAlD
Lidocaine—Paraesthesia—Cisplatin—germ cell cancer	0.000229	0.00138	CcSEcCtD
Lidocaine—ABCB1—trigeminal ganglion—germ cell cancer	0.000228	0.00344	CbGeAlD
Lidocaine—Dyspnoea—Cisplatin—germ cell cancer	0.000227	0.00137	CcSEcCtD
Lidocaine—Hyperhidrosis—Etoposide—germ cell cancer	0.000226	0.00137	CcSEcCtD
Lidocaine—CYP2C8—testis—germ cell cancer	0.000225	0.00339	CbGeAlD
Lidocaine—CYP1A2—endocrine gland—germ cell cancer	0.000221	0.00333	CbGeAlD
Lidocaine—ABCB1—embryo—germ cell cancer	0.00022	0.00332	CbGeAlD
Lidocaine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00022	0.00133	CcSEcCtD
Lidocaine—Vomiting—Bleomycin—germ cell cancer	0.00022	0.00133	CcSEcCtD
Lidocaine—Drowsiness—Methotrexate—germ cell cancer	0.000219	0.00133	CcSEcCtD
Lidocaine—Hypotension—Etoposide—germ cell cancer	0.000218	0.00132	CcSEcCtD
Lidocaine—Rash—Bleomycin—germ cell cancer	0.000218	0.00132	CcSEcCtD
Lidocaine—Pain—Cisplatin—germ cell cancer	0.000218	0.00132	CcSEcCtD
Lidocaine—Dermatitis—Bleomycin—germ cell cancer	0.000218	0.00132	CcSEcCtD
Lidocaine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000218	0.00132	CcSEcCtD
Lidocaine—SLC22A5—cerebellum—germ cell cancer	0.000215	0.00324	CbGeAlD
Lidocaine—Stomatitis—Methotrexate—germ cell cancer	0.000214	0.00129	CcSEcCtD
Lidocaine—CYP3A5—endocrine gland—germ cell cancer	0.000213	0.00321	CbGeAlD
Lidocaine—Asthenia—Ifosfamide—germ cell cancer	0.000212	0.00128	CcSEcCtD
Lidocaine—CYP2B6—endocrine gland—germ cell cancer	0.000212	0.00319	CbGeAlD
Lidocaine—Feeling abnormal—Cisplatin—germ cell cancer	0.00021	0.00127	CcSEcCtD
Lidocaine—Paraesthesia—Etoposide—germ cell cancer	0.00021	0.00127	CcSEcCtD
Lidocaine—CYP2C9—endocrine gland—germ cell cancer	0.00021	0.00316	CbGeAlD
Lidocaine—CYP2B6—head—germ cell cancer	0.000209	0.00315	CbGeAlD
Lidocaine—Dyspnoea—Etoposide—germ cell cancer	0.000208	0.00126	CcSEcCtD
Lidocaine—Somnolence—Etoposide—germ cell cancer	0.000207	0.00126	CcSEcCtD
Lidocaine—Nausea—Bleomycin—germ cell cancer	0.000205	0.00124	CcSEcCtD
Lidocaine—Vomiting—Dactinomycin—germ cell cancer	0.000205	0.00124	CcSEcCtD
Lidocaine—Rash—Dactinomycin—germ cell cancer	0.000203	0.00123	CcSEcCtD
Lidocaine—CYP2B6—testis—germ cell cancer	0.000202	0.00304	CbGeAlD
Lidocaine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000201	0.00122	CcSEcCtD
Lidocaine—Pain—Etoposide—germ cell cancer	0.0002	0.00121	CcSEcCtD
Lidocaine—Haemoglobin—Methotrexate—germ cell cancer	0.000198	0.0012	CcSEcCtD
Lidocaine—Haemorrhage—Methotrexate—germ cell cancer	0.000197	0.00119	CcSEcCtD
Lidocaine—Dizziness—Ifosfamide—germ cell cancer	0.000195	0.00118	CcSEcCtD
Lidocaine—ABCB1—retina—germ cell cancer	0.000195	0.00294	CbGeAlD
Lidocaine—Feeling abnormal—Etoposide—germ cell cancer	0.000192	0.00116	CcSEcCtD
Lidocaine—Nausea—Dactinomycin—germ cell cancer	0.000192	0.00116	CcSEcCtD
Lidocaine—Visual impairment—Methotrexate—germ cell cancer	0.00019	0.00115	CcSEcCtD
Lidocaine—Vomiting—Ifosfamide—germ cell cancer	0.000188	0.00114	CcSEcCtD
Lidocaine—Hypersensitivity—Cisplatin—germ cell cancer	0.000188	0.00114	CcSEcCtD
Lidocaine—Rash—Ifosfamide—germ cell cancer	0.000186	0.00113	CcSEcCtD
Lidocaine—Dermatitis—Ifosfamide—germ cell cancer	0.000186	0.00113	CcSEcCtD
Lidocaine—Urticaria—Etoposide—germ cell cancer	0.000185	0.00112	CcSEcCtD
Lidocaine—Eye disorder—Methotrexate—germ cell cancer	0.000184	0.00111	CcSEcCtD
Lidocaine—Tinnitus—Methotrexate—germ cell cancer	0.000183	0.00111	CcSEcCtD
Lidocaine—Asthenia—Cisplatin—germ cell cancer	0.000183	0.00111	CcSEcCtD
Lidocaine—Cardiac disorder—Methotrexate—germ cell cancer	0.000183	0.0011	CcSEcCtD
Lidocaine—ABCB1—telencephalon—germ cell cancer	0.000179	0.0027	CbGeAlD
Lidocaine—Angiopathy—Methotrexate—germ cell cancer	0.000178	0.00108	CcSEcCtD
Lidocaine—Immune system disorder—Methotrexate—germ cell cancer	0.000178	0.00108	CcSEcCtD
Lidocaine—Chills—Methotrexate—germ cell cancer	0.000177	0.00107	CcSEcCtD
Lidocaine—Nausea—Ifosfamide—germ cell cancer	0.000175	0.00106	CcSEcCtD
Lidocaine—SLC22A5—brain—germ cell cancer	0.000174	0.00263	CbGeAlD
Lidocaine—Hypersensitivity—Etoposide—germ cell cancer	0.000172	0.00104	CcSEcCtD
Lidocaine—Erythema—Methotrexate—germ cell cancer	0.000171	0.00104	CcSEcCtD
Lidocaine—EGFR—GAB1 signalosome—KITLG—germ cell cancer	0.000171	0.00286	CbGpPWpGaD
Lidocaine—ABCB1—decidua—germ cell cancer	0.00017	0.00256	CbGeAlD
Lidocaine—CYP2D6—female gonad—germ cell cancer	0.000169	0.00255	CbGeAlD
Lidocaine—CYP2C8—brain—germ cell cancer	0.000169	0.00254	CbGeAlD
Lidocaine—SLC22A5—lymph node—germ cell cancer	0.000168	0.00254	CbGeAlD
Lidocaine—Dysgeusia—Methotrexate—germ cell cancer	0.000168	0.00101	CcSEcCtD
Lidocaine—Asthenia—Etoposide—germ cell cancer	0.000167	0.00101	CcSEcCtD
Lidocaine—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—KITLG—germ cell cancer	0.000167	0.00279	CbGpPWpGaD
Lidocaine—EGFR—Bladder Cancer—MYC—germ cell cancer	0.000166	0.00278	CbGpPWpGaD
Lidocaine—EGFR—Gastric Cancer Network 2—MYC—germ cell cancer	0.000166	0.00278	CbGpPWpGaD
Lidocaine—Back pain—Methotrexate—germ cell cancer	0.000166	0.001	CcSEcCtD
Lidocaine—Vomiting—Cisplatin—germ cell cancer	0.000162	0.00098	CcSEcCtD
Lidocaine—Vision blurred—Methotrexate—germ cell cancer	0.000161	0.000977	CcSEcCtD
Lidocaine—Rash—Cisplatin—germ cell cancer	0.000161	0.000972	CcSEcCtD
Lidocaine—Dermatitis—Cisplatin—germ cell cancer	0.00016	0.000971	CcSEcCtD
Lidocaine—EGFR—Signaling by SCF-KIT—FGF4—germ cell cancer	0.00016	0.00269	CbGpPWpGaD
Lidocaine—CYP3A4—endocrine gland—germ cell cancer	0.00016	0.00241	CbGeAlD
Lidocaine—CYP2D6—endocrine gland—germ cell cancer	0.000157	0.00237	CbGeAlD
Lidocaine—EGFR—Developmental Biology—SALL4—germ cell cancer	0.000156	0.00262	CbGpPWpGaD
Lidocaine—CYP2D6—head—germ cell cancer	0.000155	0.00234	CbGeAlD
Lidocaine—Dizziness—Etoposide—germ cell cancer	0.000154	0.000934	CcSEcCtD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.000153	0.00257	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—FGF4—germ cell cancer	0.000153	0.00257	CbGpPWpGaD
Lidocaine—CYP2B6—brain—germ cell cancer	0.000151	0.00228	CbGeAlD
Lidocaine—Nausea—Cisplatin—germ cell cancer	0.000151	0.000915	CcSEcCtD
Lidocaine—EGFR—Signaling by ERBB4—FGF4—germ cell cancer	0.000151	0.00253	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—NANOG—germ cell cancer	0.00015	0.00251	CbGpPWpGaD
Lidocaine—CYP2D6—testis—germ cell cancer	0.00015	0.00226	CbGeAlD
Lidocaine—ABCB1—gonad—germ cell cancer	0.00015	0.00226	CbGeAlD
Lidocaine—ABCB1—uterus—germ cell cancer	0.000149	0.00224	CbGeAlD
Lidocaine—Convulsion—Methotrexate—germ cell cancer	0.000148	0.000898	CcSEcCtD
Lidocaine—Vomiting—Etoposide—germ cell cancer	0.000148	0.000898	CcSEcCtD
Lidocaine—Rash—Etoposide—germ cell cancer	0.000147	0.00089	CcSEcCtD
Lidocaine—Dermatitis—Etoposide—germ cell cancer	0.000147	0.000889	CcSEcCtD
Lidocaine—Headache—Etoposide—germ cell cancer	0.000146	0.000885	CcSEcCtD
Lidocaine—ABCB1—pituitary gland—germ cell cancer	0.000146	0.0022	CbGeAlD
Lidocaine—Chest pain—Methotrexate—germ cell cancer	0.000146	0.000882	CcSEcCtD
Lidocaine—EGFR—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—germ cell cancer	0.000145	0.00244	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—POU5F1—germ cell cancer	0.000144	0.00242	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—FGF4—germ cell cancer	0.000144	0.00242	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—FGF4—germ cell cancer	0.000143	0.0024	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—FGF4—germ cell cancer	0.000143	0.00239	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—FGF4—germ cell cancer	0.000142	0.00238	CbGpPWpGaD
Lidocaine—EGFR—Nanoparticle-mediated activation of receptor signaling—HRAS—germ cell cancer	0.000141	0.00237	CbGpPWpGaD
Lidocaine—Confusional state—Methotrexate—germ cell cancer	0.000141	0.000853	CcSEcCtD
Lidocaine—ABCB1—medulla oblongata—germ cell cancer	0.000141	0.00212	CbGeAlD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—FGF4—germ cell cancer	0.00014	0.00235	CbGpPWpGaD
Lidocaine—Anaphylactic shock—Methotrexate—germ cell cancer	0.00014	0.000846	CcSEcCtD
Lidocaine—EGFR—MAPK Signaling Pathway—FGF4—germ cell cancer	0.000139	0.00234	CbGpPWpGaD
Lidocaine—Nausea—Etoposide—germ cell cancer	0.000139	0.000839	CcSEcCtD
Lidocaine—CYP2D6—cerebellum—germ cell cancer	0.000138	0.00209	CbGeAlD
Lidocaine—Nervous system disorder—Methotrexate—germ cell cancer	0.000137	0.000829	CcSEcCtD
Lidocaine—EGFR—Gastric Cancer Network 2—TP53—germ cell cancer	0.000136	0.00229	CbGpPWpGaD
Lidocaine—EGFR—Bladder Cancer—TP53—germ cell cancer	0.000136	0.00229	CbGpPWpGaD
Lidocaine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000135	0.000818	CcSEcCtD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000134	0.00225	CbGpPWpGaD
Lidocaine—EGFR—GRB2 events in ERBB2 signaling—HRAS—germ cell cancer	0.000134	0.00224	CbGpPWpGaD
Lidocaine—EGFR—Extracellular vesicle-mediated signaling in recipient cells—HRAS—germ cell cancer	0.000134	0.00224	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—FGF4—germ cell cancer	0.000134	0.00224	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—FGF4—germ cell cancer	0.000134	0.00224	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—FGF4—germ cell cancer	0.000134	0.00224	CbGpPWpGaD
Lidocaine—EGFR—Constitutive PI3K/AKT Signaling in Cancer—KIT—germ cell cancer	0.000133	0.00224	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—FGF4—germ cell cancer	0.000132	0.00222	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—KITLG—germ cell cancer	0.000132	0.00221	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—FGF4—germ cell cancer	0.000131	0.0022	CbGpPWpGaD
Lidocaine—EGFR—PI-3K cascade—FGFR3—germ cell cancer	0.000131	0.00219	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—FGF4—germ cell cancer	0.000131	0.00219	CbGpPWpGaD
Lidocaine—Hypotension—Methotrexate—germ cell cancer	0.000131	0.00079	CcSEcCtD
Lidocaine—ABCB1—adrenal gland—germ cell cancer	0.00013	0.00197	CbGeAlD
Lidocaine—EGFR—Bladder Cancer—HRAS—germ cell cancer	0.00013	0.00219	CbGpPWpGaD
Lidocaine—EGFR—Hair Follicle Development: Induction (Part 1 of 3)—MYC—germ cell cancer	0.00013	0.00218	CbGpPWpGaD
Lidocaine—ABCB1—midbrain—germ cell cancer	0.000129	0.00194	CbGeAlD
Lidocaine—EGFR—PI3K/AKT activation—FGFR3—germ cell cancer	0.000128	0.00214	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000128	0.00214	CbGpPWpGaD
Lidocaine—EGFR—SHC1 events in ERBB2 signaling—HRAS—germ cell cancer	0.000127	0.00213	CbGpPWpGaD
Lidocaine—EGFR—GAB1 signalosome—FGFR3—germ cell cancer	0.000127	0.00213	CbGpPWpGaD
Lidocaine—ABCB1—bone marrow—germ cell cancer	0.000126	0.0019	CbGeAlD
Lidocaine—EGFR—Downstream signaling of activated FGFR—KITLG—germ cell cancer	0.000126	0.00211	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000126	0.00211	CbGpPWpGaD
Lidocaine—ABCB1—spinal cord—germ cell cancer	0.000126	0.00189	CbGeAlD
Lidocaine—Paraesthesia—Methotrexate—germ cell cancer	0.000126	0.000759	CcSEcCtD
Lidocaine—Dyspnoea—Methotrexate—germ cell cancer	0.000125	0.000754	CcSEcCtD
Lidocaine—Somnolence—Methotrexate—germ cell cancer	0.000124	0.000752	CcSEcCtD
Lidocaine—EGFR—Signaling by ERBB4—KITLG—germ cell cancer	0.000124	0.00208	CbGpPWpGaD
Lidocaine—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—germ cell cancer	0.000124	0.00208	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—FGF4—germ cell cancer	0.000124	0.00207	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—SOX2—germ cell cancer	0.000122	0.00205	CbGpPWpGaD
Lidocaine—ABCB1—female gonad—germ cell cancer	0.000122	0.00183	CbGeAlD
Lidocaine—EGFR—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000121	0.00203	CbGpPWpGaD
Lidocaine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000121	0.00073	CcSEcCtD
Lidocaine—EGFR—PI-3K cascade—KIT—germ cell cancer	0.00012	0.00201	CbGpPWpGaD
Lidocaine—Pain—Methotrexate—germ cell cancer	0.00012	0.000723	CcSEcCtD
Lidocaine—EGFR—Downstream signal transduction—KITLG—germ cell cancer	0.000118	0.00198	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—FGF4—germ cell cancer	0.000118	0.00198	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—KITLG—germ cell cancer	0.000118	0.00198	CbGpPWpGaD
Lidocaine—EGFR—PI3K/AKT activation—KIT—germ cell cancer	0.000117	0.00197	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—KITLG—germ cell cancer	0.000117	0.00197	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—KITLG—germ cell cancer	0.000117	0.00196	CbGpPWpGaD
Lidocaine—EGFR—GAB1 signalosome—KIT—germ cell cancer	0.000116	0.00195	CbGpPWpGaD
Lidocaine—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000116	0.00194	CbGpPWpGaD
Lidocaine—Feeling abnormal—Methotrexate—germ cell cancer	0.000115	0.000697	CcSEcCtD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KITLG—germ cell cancer	0.000115	0.00193	CbGpPWpGaD
Lidocaine—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—germ cell cancer	0.000114	0.00191	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—KLF4—germ cell cancer	0.000114	0.00191	CbGpPWpGaD
Lidocaine—ABCB1—endocrine gland—germ cell cancer	0.000113	0.0017	CbGeAlD
Lidocaine—CYP2D6—brain—germ cell cancer	0.000112	0.0017	CbGeAlD
Lidocaine—ABCB1—head—germ cell cancer	0.000112	0.00168	CbGeAlD
Lidocaine—Urticaria—Methotrexate—germ cell cancer	0.000111	0.000672	CcSEcCtD
Lidocaine—EGFR—Internalization of ErbB1—HRAS—germ cell cancer	0.000111	0.00186	CbGpPWpGaD
Lidocaine—CYP2A6—Fluoropyrimidine Activity—TP53—germ cell cancer	0.00011	0.00184	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—KITLG—germ cell cancer	0.00011	0.00184	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—KITLG—germ cell cancer	0.00011	0.00184	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—KITLG—germ cell cancer	0.00011	0.00184	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—KITLG—germ cell cancer	0.000109	0.00182	CbGpPWpGaD
Lidocaine—ABCB1—testis—germ cell cancer	0.000108	0.00163	CbGeAlD
Lidocaine—EGFR—Signaling by EGFR in Cancer—KITLG—germ cell cancer	0.000108	0.00181	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—KITLG—germ cell cancer	0.000107	0.0018	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—MYC—germ cell cancer	0.000106	0.00179	CbGpPWpGaD
Lidocaine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000106	0.00177	CbGpPWpGaD
Lidocaine—Hypersensitivity—Methotrexate—germ cell cancer	0.000103	0.000623	CcSEcCtD
Lidocaine—EGFR—B Cell Activation—KITLG—germ cell cancer	0.000102	0.0017	CbGpPWpGaD
Lidocaine—Asthenia—Methotrexate—germ cell cancer	0.0001	0.000607	CcSEcCtD
Lidocaine—ABCB1—cerebellum—germ cell cancer	9.96e-05	0.0015	CbGeAlD
Lidocaine—EGFR—Signaling by SCF-KIT—FGFR3—germ cell cancer	9.78e-05	0.00164	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	9.72e-05	0.00163	CbGpPWpGaD
Lidocaine—EGFR—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	9.68e-05	0.00162	CbGpPWpGaD
Lidocaine—EGFR—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	9.51e-05	0.00159	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—FGFR3—germ cell cancer	9.36e-05	0.00157	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	9.36e-05	0.00157	CbGpPWpGaD
Lidocaine—Dizziness—Methotrexate—germ cell cancer	9.24e-05	0.000559	CcSEcCtD
Lidocaine—EGFR—Signaling by ERBB4—FGFR3—germ cell cancer	9.21e-05	0.00154	CbGpPWpGaD
Lidocaine—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—germ cell cancer	9.19e-05	0.00154	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	9.18e-05	0.00154	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—FGF4—germ cell cancer	9.1e-05	0.00153	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—KIT—germ cell cancer	8.98e-05	0.00151	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	8.96e-05	0.0015	CbGpPWpGaD
Lidocaine—Vomiting—Methotrexate—germ cell cancer	8.89e-05	0.000538	CcSEcCtD
Lidocaine—EGFR—Regulation of Telomerase—MYC—germ cell cancer	8.86e-05	0.00149	CbGpPWpGaD
Lidocaine—Rash—Methotrexate—germ cell cancer	8.81e-05	0.000533	CcSEcCtD
Lidocaine—Dermatitis—Methotrexate—germ cell cancer	8.8e-05	0.000533	CcSEcCtD
Lidocaine—EGFR—Downstream signal transduction—FGFR3—germ cell cancer	8.8e-05	0.00148	CbGpPWpGaD
Lidocaine—Headache—Methotrexate—germ cell cancer	8.76e-05	0.00053	CcSEcCtD
Lidocaine—EGFR—Signaling by FGFR—FGFR3—germ cell cancer	8.75e-05	0.00147	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—TP53—germ cell cancer	8.75e-05	0.00147	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—FGFR3—germ cell cancer	8.71e-05	0.00146	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—FGFR3—germ cell cancer	8.67e-05	0.00145	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—KIT—germ cell cancer	8.59e-05	0.00144	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—germ cell cancer	8.54e-05	0.00143	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—KIT—germ cell cancer	8.46e-05	0.00142	CbGpPWpGaD
Lidocaine—EGFR—ErbB Signaling Pathway—HRAS—germ cell cancer	8.36e-05	0.0014	CbGpPWpGaD
Lidocaine—Nausea—Methotrexate—germ cell cancer	8.3e-05	0.000502	CcSEcCtD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	8.15e-05	0.00137	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—FGFR3—germ cell cancer	8.15e-05	0.00137	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—FGFR3—germ cell cancer	8.15e-05	0.00137	CbGpPWpGaD
Lidocaine—ABCB1—brain—germ cell cancer	8.09e-05	0.00122	CbGeAlD
Lidocaine—EGFR—Signaling by EGFR—FGFR3—germ cell cancer	8.08e-05	0.00136	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—KIT—germ cell cancer	8.08e-05	0.00135	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—KIT—germ cell cancer	8.04e-05	0.00135	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	8.01e-05	0.00134	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—SOX2—germ cell cancer	8.01e-05	0.00134	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—KIT—germ cell cancer	8e-05	0.00134	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—FGFR3—germ cell cancer	7.98e-05	0.00134	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—KIT—germ cell cancer	7.96e-05	0.00133	CbGpPWpGaD
Lidocaine—EGFR—SHP2 signaling—HRAS—germ cell cancer	7.9e-05	0.00132	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PVRL2—germ cell cancer	7.89e-05	0.00132	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KIT—germ cell cancer	7.84e-05	0.00132	CbGpPWpGaD
Lidocaine—ABCB1—lymph node—germ cell cancer	7.82e-05	0.00118	CbGeAlD
Lidocaine—EGFR—B Cell Activation—FGFR3—germ cell cancer	7.55e-05	0.00127	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	7.49e-05	0.00126	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—KIT—germ cell cancer	7.49e-05	0.00126	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—KIT—germ cell cancer	7.49e-05	0.00126	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—KITLG—germ cell cancer	7.47e-05	0.00125	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—KIT—germ cell cancer	7.42e-05	0.00124	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	7.36e-05	0.00123	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—KIT—germ cell cancer	7.35e-05	0.00123	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—KIT—germ cell cancer	7.32e-05	0.00123	CbGpPWpGaD
Lidocaine—EGFR—LPA receptor mediated events—HRAS—germ cell cancer	7.3e-05	0.00122	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	7.22e-05	0.00121	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	7.04e-05	0.00118	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—KIT—germ cell cancer	6.93e-05	0.00116	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.7e-05	0.00112	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	6.63e-05	0.00111	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—TP53—germ cell cancer	6.26e-05	0.00105	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—HRAS—germ cell cancer	5.99e-05	0.001	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	5.88e-05	0.000987	CbGpPWpGaD
Lidocaine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	5.81e-05	0.000974	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—MYC—germ cell cancer	5.7e-05	0.000956	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—SLC2A3—germ cell cancer	5.66e-05	0.00095	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—SLC22A3—germ cell cancer	5.58e-05	0.000936	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—FGFR3—germ cell cancer	5.56e-05	0.000932	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—FGF4—germ cell cancer	5.19e-05	0.00087	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—KIT—germ cell cancer	5.1e-05	0.000855	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—FGF4—germ cell cancer	4.98e-05	0.000836	CbGpPWpGaD
Lidocaine—EGFR—ErbB1 downstream signaling—HRAS—germ cell cancer	4.91e-05	0.000824	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—HRAS—germ cell cancer	4.89e-05	0.00082	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	4.88e-05	0.000818	CbGpPWpGaD
Lidocaine—EGFR—Disease—SLC2A3—germ cell cancer	4.86e-05	0.000815	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PVRL2—germ cell cancer	4.78e-05	0.000802	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—TP53—germ cell cancer	4.68e-05	0.000785	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—MYC—germ cell cancer	4.68e-05	0.000785	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—HRAS—germ cell cancer	4.68e-05	0.000784	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CRABP1—germ cell cancer	4.55e-05	0.000763	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—HRAS—germ cell cancer	4.49e-05	0.000754	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—HRAS—germ cell cancer	4.49e-05	0.000754	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.38e-05	0.000735	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—HRAS—germ cell cancer	4.33e-05	0.000727	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.32e-05	0.000724	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—MYC—germ cell cancer	4.3e-05	0.00072	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—KITLG—germ cell cancer	4.26e-05	0.000715	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.25e-05	0.000713	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KITLG—germ cell cancer	4.09e-05	0.000687	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—germ cell cancer	4.08e-05	0.000684	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—HRAS—germ cell cancer	3.88e-05	0.000651	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	3.88e-05	0.00065	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—OXT—germ cell cancer	3.88e-05	0.00065	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—germ cell cancer	3.84e-05	0.000644	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.83e-05	0.000643	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—SLC2A3—germ cell cancer	3.77e-05	0.000631	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—HRAS—germ cell cancer	3.71e-05	0.000623	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—SLC22A3—germ cell cancer	3.71e-05	0.000622	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—HRAS—germ cell cancer	3.65e-05	0.000613	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—germ cell cancer	3.53e-05	0.000592	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—HRAS—germ cell cancer	3.49e-05	0.000585	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—HRAS—germ cell cancer	3.49e-05	0.000585	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	3.47e-05	0.000582	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—HRAS—germ cell cancer	3.47e-05	0.000582	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.46e-05	0.00058	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—HRAS—germ cell cancer	3.46e-05	0.00058	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—SLC2A3—germ cell cancer	3.45e-05	0.000579	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—HRAS—germ cell cancer	3.44e-05	0.000577	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—SLC22A3—germ cell cancer	3.4e-05	0.00057	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	3.39e-05	0.000568	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—HRAS—germ cell cancer	3.34e-05	0.00056	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—HRAS—germ cell cancer	3.24e-05	0.000543	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—HRAS—germ cell cancer	3.24e-05	0.000543	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	3.24e-05	0.000543	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—HRAS—germ cell cancer	3.21e-05	0.000538	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—HRAS—germ cell cancer	3.21e-05	0.000538	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—HRAS—germ cell cancer	3.21e-05	0.000538	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.18e-05	0.000534	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—HRAS—germ cell cancer	3.18e-05	0.000533	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—FGFR3—germ cell cancer	3.17e-05	0.000531	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—HRAS—germ cell cancer	3.16e-05	0.000531	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—HRAS—germ cell cancer	3.09e-05	0.000519	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—HRAS—germ cell cancer	3.06e-05	0.000513	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—HRAS—germ cell cancer	3.05e-05	0.000511	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—FGFR3—germ cell cancer	3.04e-05	0.00051	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CRABP1—germ cell cancer	3.02e-05	0.000507	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FGF4—germ cell cancer	3.02e-05	0.000507	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—HRAS—germ cell cancer	2.99e-05	0.000502	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.96e-05	0.000496	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—KIT—germ cell cancer	2.91e-05	0.000488	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	2.87e-05	0.000481	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—KIT—germ cell cancer	2.79e-05	0.000468	CbGpPWpGaD
Lidocaine—EGFR—Disease—FGF4—germ cell cancer	2.79e-05	0.000468	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—SLC2A3—germ cell cancer	2.78e-05	0.000467	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CRABP1—germ cell cancer	2.77e-05	0.000465	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	2.77e-05	0.000464	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—SLC22A3—germ cell cancer	2.74e-05	0.00046	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—SLC2A3—germ cell cancer	2.72e-05	0.000456	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—SLC22A3—germ cell cancer	2.68e-05	0.00045	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AVP—germ cell cancer	2.66e-05	0.000445	CbGpPWpGaD
Lidocaine—EGFR—Disease—H2AFZ—germ cell cancer	2.49e-05	0.000418	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KITLG—germ cell cancer	2.48e-05	0.000416	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SLC2A3—germ cell cancer	2.36e-05	0.000395	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SLC22A3—germ cell cancer	2.32e-05	0.000389	CbGpPWpGaD
Lidocaine—EGFR—Disease—KITLG—germ cell cancer	2.29e-05	0.000384	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—OXT—germ cell cancer	2.29e-05	0.000384	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CRABP1—germ cell cancer	2.24e-05	0.000375	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—HRAS—germ cell cancer	2.2e-05	0.00037	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CRABP1—germ cell cancer	2.19e-05	0.000366	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HRAS—germ cell cancer	2.17e-05	0.000365	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.05e-05	0.000344	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.02e-05	0.000339	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.02e-05	0.000339	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—HRAS—germ cell cancer	1.99e-05	0.000335	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.96e-05	0.000328	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGF4—germ cell cancer	1.95e-05	0.000328	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SLC2A3—germ cell cancer	1.94e-05	0.000325	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SLC2A3—germ cell cancer	1.92e-05	0.000322	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SLC22A3—germ cell cancer	1.91e-05	0.00032	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CRABP1—germ cell cancer	1.89e-05	0.000317	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SLC22A3—germ cell cancer	1.89e-05	0.000317	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FGFR3—germ cell cancer	1.85e-05	0.000309	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—H2AFZ—germ cell cancer	1.75e-05	0.000293	CbGpPWpGaD
Lidocaine—EGFR—Disease—FGFR3—germ cell cancer	1.7e-05	0.000286	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KIT—germ cell cancer	1.69e-05	0.000284	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CRABP1—germ cell cancer	1.65e-05	0.000277	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC2A3—germ cell cancer	1.64e-05	0.000275	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC22A3—germ cell cancer	1.61e-05	0.000271	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.61e-05	0.000269	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KITLG—germ cell cancer	1.61e-05	0.000269	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AVP—germ cell cancer	1.57e-05	0.000263	CbGpPWpGaD
Lidocaine—EGFR—Disease—KIT—germ cell cancer	1.56e-05	0.000262	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.55e-05	0.000261	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CRABP1—germ cell cancer	1.54e-05	0.000258	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HRAS—germ cell cancer	1.42e-05	0.000239	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CRABP1—germ cell cancer	1.32e-05	0.000221	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.27e-05	0.000212	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—HRAS—germ cell cancer	1.26e-05	0.000211	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.25e-05	0.000209	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HRAS—germ cell cancer	1.21e-05	0.000202	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGFR3—germ cell cancer	1.19e-05	0.0002	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KIT—germ cell cancer	1.1e-05	0.000184	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.02e-05	0.00017	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—germ cell cancer	8.61e-06	0.000144	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—germ cell cancer	8.01e-06	0.000134	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—germ cell cancer	7.32e-06	0.000123	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—germ cell cancer	6.76e-06	0.000113	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—germ cell cancer	6.03e-06	0.000101	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—germ cell cancer	4.95e-06	8.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—germ cell cancer	4.73e-06	7.94e-05	CbGpPWpGaD
